Page last updated: 2024-11-04

vorinostat and Degenerative Diseases, Central Nervous System

vorinostat has been researched along with Degenerative Diseases, Central Nervous System in 7 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Song, Y1
Lim, J1
Seo, YH1
Athaide Rocha, KM1
Machado, FR1
Poetini, M1
Giacomeli, R1
Boeira, SP1
Jesse, CR1
Gomes de Gomes, M1
Alqinyah, M1
Hooks, SB1
Cao, F1
Zwinderman, MRH1
Dekker, FJ1
Takamatsu, G1
Katagiri, C1
Tomoyuki, T1
Shimizu-Okabe, C1
Nakamura, W1
Nakamura-Higa, M1
Hayakawa, T1
Wakabayashi, S1
Kondo, T1
Takayama, C1
Matsushita, M1
Hori, S1
Kakizuka, A1
Rouaux, C1
Loeffler, JP1
Boutillier, AL1

Reviews

4 reviews available for vorinostat and Degenerative Diseases, Central Nervous System

ArticleYear
Regulating the regulators: Epigenetic, transcriptional, and post-translational regulation of RGS proteins.
    Cellular signalling, 2018, Volume: 42

    Topics: Animals; Azacitidine; Benzodiazepines; Cardiovascular Diseases; Drugs, Investigational; Epigenesis,

2018
The Process and Strategy for Developing Selective Histone Deacetylase 3 Inhibitors.
    Molecules (Basel, Switzerland), 2018, Mar-02, Volume: 23, Issue:3

    Topics: Antineoplastic Agents; Chemistry Techniques, Synthetic; Depsipeptides; Drug Design; Epigenesis, Gene

2018
[Therapeutic targets in polyglutamine diseases].
    Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 2004, Volume: 49, Issue:7 Suppl

    Topics: Adenosine Triphosphatases; Animals; Antineoplastic Agents; Benzoquinones; Cell Cycle Proteins; Congo

2004
Targeting CREB-binding protein (CBP) loss of function as a therapeutic strategy in neurological disorders.
    Biochemical pharmacology, 2004, Sep-15, Volume: 68, Issue:6

    Topics: Animals; Apoptosis; CREB-Binding Protein; Drug Delivery Systems; Enzyme Inhibitors; Histone Deacetyl

2004

Other Studies

3 other studies available for vorinostat and Degenerative Diseases, Central Nervous System

ArticleYear
A novel class of anthraquinone-based HDAC6 inhibitors.
    European journal of medicinal chemistry, 2019, Feb-15, Volume: 164

    Topics: Acetylation; Anthraquinones; Cell Line, Tumor; Enzyme Assays; Histone Deacetylase 6; Histone Deacety

2019
Assessment of suberoylanilide hydroxamic acid on a Alzheimer's disease model induced by β-amyloid
    Chemico-biological interactions, 2023, Apr-25, Volume: 375

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain-Derived Neurotrophic Factor; Epigenesis, Ge

2023
Tescalcin is a potential target of class I histone deacetylase inhibitors in neurons.
    Biochemical and biophysical research communications, 2017, Jan-22, Volume: 482, Issue:4

    Topics: Animals; Calcineurin; Calcium; Calcium-Binding Proteins; Cluster Analysis; Epigenesis, Genetic; Gene

2017